You have 9 free searches left this month | for more free features.

gsk2118436

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Trial in Australia, United States (GSK2118436, GSK1120212)

Completed
  • Cancer
  • Los Angeles, California
  • +14 more
Jun 25, 2019

Cancer Trial in Worldwide (GSK2118436, GSK1120212, Other approved anti-cancer agent)

Completed
  • Cancer
  • GSK2118436
  • +2 more
  • Goodyear, Arizona
  • +43 more
Mar 20, 2019

Cancer Trial in Tacoma (GSK2118436)

Completed
  • Cancer
  • GSK2118436
  • Tacoma, Washington
    GSK Investigational Site
Nov 8, 2017

Cancer Trial in Tacoma (GSK2118436)

Completed
  • Cancer
  • GSK2118436
  • Tacoma, Washington
    GSK Investigational Site
Nov 8, 2017

Cancer Trial in Shizuoka, Tokyo (GSK2118436)

Completed
  • Cancer
  • GSK2118436
  • Shizuoka, Japan
  • +1 more
Nov 8, 2017

Cancer Trial in Australia, United States (GSK2118436, Midazolam)

Completed
  • Cancer
  • Los Angeles, California
  • +7 more
Nov 8, 2017

Melanoma Trial in Worldwide (GSK2118436)

Completed
  • Melanoma
  • GSK2118436
  • Los Angeles, California
  • +22 more
Aug 29, 2017

Cancer Trial in Worldwide (GSK2118436, Dacarbazine (DTIC))

Completed
  • Cancer
  • GSK2118436
  • Dacarbazine (DTIC)
  • Birmingham, Alabama
  • +93 more
Sep 6, 2017

Papillary Thyroid Carcinoma Trial in Boston (GSK2118436)

Completed
  • Papillary Thyroid Carcinoma
  • GSK2118436
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 24, 2017

Melanoma Trial in Houston (GSK2118436, GSK1120212)

Completed
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 19, 2016

Melanoma and Brain Metastases Trial in Worldwide (GSK2118436)

Completed
  • Melanoma and Brain Metastases
  • GSK2118436
  • Los Angeles, California
  • +23 more
Apr 24, 2014